<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en"><title>The latest in Medical Drug Therapy</title><link href="http://www.factsaboutheadaches.com/topic/Medical%20Drug%20Therapy" rel="alternate"></link><id>http://www.factsaboutheadaches.com/topic/Medical Drug Therapy</id><updated>2010-03-15T10:17:45Z</updated><entry><title>Tissue-freezing balloon beats drugs in ablation study</title><link href="http://www.factsaboutheadaches.com/article/Tissue-freezing%20balloon%20beats%20drugs%20in%20ablation%20study" rel="alternate"></link><updated>2010-03-15T10:17:45Z</updated><author><name>AFP Global Edition</name></author><id>tag:www.factsaboutheadaches.com,2010-03-15:/article/Tissue-freezing%20balloon%20beats%20drugs%20in%20ablation%20study</id><summary type="html">&amp;lt;div&amp;gt;&amp;lt;p&amp;gt;An experimental ablation therapy system that freezes heart tissue with a balloon catheter to treat a common heart rhythm disorder is far more effective than drug therapy, a study found Monday.&amp;lt;/p&amp;gt;&amp;lt;p&amp;gt;Researchers compared the safety and efficacy of the Arctic Front CryoAblation Catheter System produced by US firm &lt;a title="Medtronic Inc." href="/topic/Medtronic+Inc." &gt;Medtronic&lt;/a&gt; to drug therapy over at least one year in 245 patients in the &lt;a title="United States...</summary><category term="Medical Treatments and Procedures"></category><category term="Medical Drug Therapy"></category><category term="Medical Equipment and Supplies"></category><category term="Electromedical Apparatus Manufacturing"></category><category term="Oceania"></category><category term="Cardiovascular Medicine"></category><category term="Douglas Packer"></category></entry><entry><title>Cryogenic balloon offers hope to heart patients</title><link href="http://www.factsaboutheadaches.com/article/Cryogenic%20balloon%20offers%20hope%20to%20heart%20patients" rel="alternate"></link><updated>2010-03-15T08:15:51Z</updated><author><name>AFP Global Edition</name></author><id>tag:www.factsaboutheadaches.com,2010-03-15:/article/Cryogenic%20balloon%20offers%20hope%20to%20heart%20patients</id><summary type="html">&amp;lt;div&amp;gt;&amp;lt;p&amp;gt;An experimental ablation therapy system that freezes heart tissue with a balloon catheter to treat a common heart rhythm disorder is far more effective than drug therapy, a study found Monday.&amp;lt;/p&amp;gt;&amp;lt;p&amp;gt;Researchers compared the safety and efficacy of the Arctic Front CryoAblation Catheter System produced by US firm &lt;a title="Medtronic Inc." href="/topic/Medtronic+Inc." &gt;Medtronic&lt;/a&gt; to drug therapy over at least one year in 245 patients in the &lt;a title="United States...</summary><category term="Medical Treatments and Procedures"></category><category term="Medical Drug Therapy"></category><category term="Medical Equipment and Supplies"></category><category term="Electromedical Apparatus Manufacturing"></category><category term="Oceania"></category><category term="Cardiovascular Medicine"></category><category term="Douglas Packer"></category></entry><entry><title>Pfizer ends study on potential lung cancer drug</title><link href="http://www.factsaboutheadaches.com/article/Pfizer%20ends%20study%20on%20potential%20lung%20cancer%20drug" rel="alternate"></link><updated>2010-03-11T15:30:17Z</updated><author><name>AP News</name></author><id>tag:www.factsaboutheadaches.com,2010-03-11:/article/Pfizer%20ends%20study%20on%20potential%20lung%20cancer%20drug</id><summary type="html">&amp;lt;div id="subtitle"&amp;gt;&lt;a title="Pfizer Inc." href="/topic/Pfizer+Inc." &gt;Pfizer&lt;/a&gt; ends study on potential lung cancer drug, committee says it won't meet treatment goal&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;&amp;lt;p&amp;gt;Pfizer Inc. said Thursday it discontinued a late-stage study of the drug candidate figitumumab in patients with late-stage lung cancer, citing a lack of effectiveness.&amp;lt;/p&amp;gt;&amp;lt;p&amp;gt;The company said an independent monitoring committee recommended stopping the study. It concluded that figitumu...</summary><category term="Cancer"></category><category term="Lung Cancer"></category><category term="Clinical Trials"></category><category term="Medical Treatments and Procedures"></category><category term="Medical Drug Therapy"></category><category term="OSI Pharmaceuticals Inc."></category><category term="Mace Rothenberg"></category></entry><entry><title>Watson says FDA approves 6-month dose Trelstar</title><link href="http://www.factsaboutheadaches.com/article/Watson%20says%20FDA%20approves%206-month%20dose%20Trelstar" rel="alternate"></link><updated>2010-03-11T15:00:28Z</updated><author><name>AP News</name></author><id>tag:www.factsaboutheadaches.com,2010-03-11:/article/Watson%20says%20FDA%20approves%206-month%20dose%20Trelstar</id><summary type="html">&amp;lt;div id="subtitle"&amp;gt;&lt;a title="Watson Pharmaceuticals Inc." href="/topic/Watson+Pharmaceuticals+Inc." &gt;Watson Pharmaceuticals&lt;/a&gt; says FDA approves 6-month dose of prostate cancer drug Trelstar&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;&amp;lt;p&amp;gt;Watson Pharmaceuticals Inc. said the &lt;a title="Food and Drug Administration" href="/topic/Food+and+Drug+Administration" &gt;Food and Drug Administration&lt;/a&gt; approved a six-month dose of the prostate cancer drug Trelstar, which already was available in one- and three-month d...</summary><category term="Cancer"></category><category term="Prostate Cancer"></category><category term="Medical Treatments and Procedures"></category><category term="Medical Drug Therapy"></category><category term="Sexual and Reproductive Health"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="Men's Health"></category><category term="Western Europe"></category><category term="Watson Pharmaceuticals Inc."></category><category term="Chemotherapy"></category><category term="Debiopharm SA"></category></entry><entry><title>Hormone Replacement Therapy Still Good For Menopause?</title><link href="http://www.factsaboutheadaches.com/article/Hormone%20Replacement%20Therapy%20Still%20Good%20For%20Menopause%3F" rel="alternate"></link><updated>2010-03-10T18:14:23Z</updated><author><name>isnare</name></author><id>tag:www.factsaboutheadaches.com,2010-03-10:/article/Hormone%20Replacement%20Therapy%20Still%20Good%20For%20Menopause%3F</id><summary type="html">&lt;p&gt;Hormone replacement therapy, now more commonly known as hormone therapy, use to be medical worlds standard treatment for those women suffering from hot flashes and other side effects of going through menopause. They also thought that it could help prevent osteoporosis and even heart disease.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;In 2002 however; the minds of many in the medical field changed when they saw the results of a clinical test. What the test uncovered is that the hormone replacement therapy could actua...</summary><category term="Cancer"></category><category term="Breast Cancer"></category><category term="Breast Cancer Treatment"></category><category term="Geriatric Medicine"></category><category term="Osteoporosis"></category><category term="Menopause"></category><category term="Orthopedics"></category><category term="Medical Treatments and Procedures"></category><category term="Medical Drug Therapy"></category><category term="Social Issues"></category><category term="Women's Issues"></category><category term="Women's Health"></category><category term="Cardiovascular Medicine"></category><category term="Hormone Therapies"></category></entry><entry><title>Drug industry pays for Mo. cold medicine database</title><link href="http://www.factsaboutheadaches.com/article/Drug%20industry%20pays%20for%20Mo.%20cold%20medicine%20database" rel="alternate"></link><updated>2010-03-08T13:18:32Z</updated><author><name>AP News</name></author><id>tag:www.factsaboutheadaches.com,2010-03-08:/article/Drug%20industry%20pays%20for%20Mo.%20cold%20medicine%20database</id><summary type="html">&amp;lt;div id="subtitle"&amp;gt;Drug industry to pay for Mo. database tracking purchases of cold medicines used to make meth&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;&amp;lt;p&amp;gt;Missouri selected a company Monday to develop a database for tracking purchases of cold medicine that can be used to make methamphetamine.&amp;lt;/p&amp;gt;&amp;lt;p&amp;gt;Since 2005, &lt;a title="Missouri" href="/topic/Missouri" &gt;Missouri&lt;/a&gt; has kept a paper log that law officers can check later to track purchases of cold medications containing pseudoephedrine. A 2...</summary><category term="Crime"></category><category term="Police"></category><category term="Contagious and Infectious Diseases"></category><category term="Common Cold"></category><category term="Medical Treatments and Procedures"></category><category term="Medical Drug Therapy"></category><category term="Methamphetamine"></category><category term="Sudafed"></category><category term="Franklin County"></category><category term="Jay Nixon"></category><category term="Drug Crimes"></category><category term="Psychoactive Drugs"></category><category term="Methamphetamine Crimes"></category><category term="Louisville (Kentucky)"></category><category term="Appriss Inc."></category></entry><entry><title>Sanofi drug shows promise against prostate cancer</title><link href="http://www.factsaboutheadaches.com/article/Sanofi%20drug%20shows%20promise%20against%20prostate%20cancer" rel="alternate"></link><updated>2010-03-03T15:16:06Z</updated><author><name>AP News</name></author><id>tag:www.factsaboutheadaches.com,2010-03-03:/article/Sanofi%20drug%20shows%20promise%20against%20prostate%20cancer</id><summary type="html">&amp;lt;div id="subtitle"&amp;gt;Experimental drug modestly boosts survival in men with advanced prostate cancer, study finds&amp;lt;/div&amp;gt;&amp;lt;div&amp;gt;&amp;lt;p&amp;gt;For the first time, an experimental drug has extended the lives of men with advanced prostate cancer who are no longer responding to other treatments and are out of options for fighting the disease, a company-led study found.&amp;lt;/p&amp;gt;&amp;lt;p&amp;gt;The benefit was modest — an extra 10 weeks — but cancer specialists were excited because no chemotherapy un...</summary><category term="Cancer"></category><category term="Prostate Cancer"></category><category term="Medical Treatments and Procedures"></category><category term="Medical Drug Therapy"></category><category term="Vaccines"></category><category term="Sexual and Reproductive Health"></category><category term="Men's Health"></category><category term="OSI Pharmaceuticals Inc."></category><category term="Taxotere"></category><category term="Dendreon Corporation"></category><category term="Nicholas Vogelzang"></category><category term="Chemotherapy"></category><category term="Provenge"></category></entry><entry><title>FDA Considers New Restrictions On Pain Relievers Containing Acetaminophen</title><link href="http://www.factsaboutheadaches.com/photo/1366463" rel="alternate"></link><updated>2010-02-25T11:31:09Z</updated><author><name>Getty Images</name></author><id>tag:www.factsaboutheadaches.com,2010-02-25:/photo/1366463</id><summary type="html">&lt;a title="Chicago" href="/topic/Chicago" &gt;CHICAGO&lt;/a&gt; - JUNE 30:  &lt;a title="Theraflu" href="/topic/Theraflu" &gt;Theraflu&lt;/a&gt; cold medicine is sold over-the-counter at a drugstore June 30, 2009 in Chicago, &lt;a title="Illinois" href="/topic/Illinois" &gt;Illinois&lt;/a&gt;. Theraflu contains acetaminophen, an active ingredient found in many pain killers and cold medicines. Today the &lt;a title="Food and Drug Administration" href="/topic/Food+and+Drug+Administration" &gt;Food and Drug Administration&lt;/a&gt;'s advisory ...</summary><category term="Medicine"></category><category term="Contagious and Infectious Diseases"></category><category term="Common Cold"></category><category term="Medical Specializations"></category><category term="Internal Medicine"></category><category term="Liver Diseases"></category><category term="Medical Treatments and Procedures"></category><category term="Medical Drug Therapy"></category><category term="Getty Images Inc."></category><category term="Theraflu"></category></entry><entry><title>Roche's Avastin fails in stomach cancer trial</title><link href="http://www.factsaboutheadaches.com/article/Roche%27s%20Avastin%20fails%20in%20stomach%20cancer%20trial" rel="alternate"></link><updated>2010-02-23T01:30:09Z</updated><author><name>Reuters US Online Report Health News</name></author><id>tag:www.factsaboutheadaches.com,2010-02-23:/article/Roche%27s%20Avastin%20fails%20in%20stomach%20cancer%20trial</id><summary type="html">&amp;lt;div&amp;gt;&amp;lt;p&amp;gt;ZURICH (&lt;a title="Reuters Group plc" href="/topic/Reuters+Group+plc" &gt;Reuters&lt;/a&gt;) - &lt;a title="F. Hoffman-La Roche Ltd." href="/topic/F.+Hoffman-La+Roche+Ltd." &gt;Roche Holding&lt;/a&gt;'s cancer drug &lt;a title="Avastin" href="/topic/Avastin" &gt;Avastin&lt;/a&gt; missed its main target in a late-stage trial when used with chemotherapy to treat patients with advanced stomach cancer, the Swiss drugmaker said on Tuesday.&amp;lt;/p&amp;gt;&amp;lt;p&amp;gt;Roche had indicated peak sales of the drug for the diseas...</summary><category term="Cancer"></category><category term="Stomach Cancer"></category><category term="Medical Treatments and Procedures"></category><category term="Medical Drug Therapy"></category><category term="Banking Services"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="Reuters Group plc"></category><category term="F. Hoffman-La Roche Ltd."></category><category term="Mike Nesbit"></category><category term="Chemotherapy"></category><category term="Dow Jones STOXX Indices"></category><category term="Martin Voegtli"></category></entry><entry><title>Roche's Rituxan gets US OK for another cancer</title><link href="http://www.factsaboutheadaches.com/article/Roche%27s%20Rituxan%20gets%20US%20OK%20for%20another%20cancer" rel="alternate"></link><updated>2010-02-22T08:35:22Z</updated><author><name>AP News</name></author><id>tag:www.factsaboutheadaches.com,2010-02-22:/article/Roche%27s%20Rituxan%20gets%20US%20OK%20for%20another%20cancer</id><summary type="html">&amp;amp;lt;div id="subtitle"&amp;amp;gt;Roche's &lt;a title="Genentech Inc." href="/topic/Genentech+Inc." &gt;Genentech&lt;/a&gt; gets &lt;a title="United States" href="/topic/United+States" &gt;US&lt;/a&gt; OK for blockbuster blood cancer drug &lt;a title="Rituxan" href="/topic/Rituxan" &gt;Rituxan&lt;/a&gt; to treat another cancer&amp;amp;lt;/div&amp;amp;gt;&amp;amp;lt;div&amp;amp;gt;&amp;amp;lt;p&amp;amp;gt;Genentech's blockbuster blood cancer drug Rituxan was approved Thursday for a new use by the &lt;a title="Food and Drug Administration" href="/topic/Food+an...</summary><category term="Cancer"></category><category term="Leukemia"></category><category term="Medical Treatments and Procedures"></category><category term="Medical Drug Therapy"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="F. Hoffman-La Roche Ltd."></category><category term="MabThera"></category><category term="Chemotherapy"></category></entry><entry><title>Growth hormone therapy more common in boys</title><link href="http://www.factsaboutheadaches.com/article/Growth%20hormone%20therapy%20more%20common%20in%20boys" rel="alternate"></link><updated>2010-02-22T12:16:19Z</updated><author><name>Reuters US Online Report Health News</name></author><id>tag:www.factsaboutheadaches.com,2010-02-22:/article/Growth%20hormone%20therapy%20more%20common%20in%20boys</id><summary type="html">&amp;amp;lt;div&amp;amp;gt;&amp;amp;lt;p&amp;amp;gt;NEW YORK (&lt;a title="Reuters Group plc" href="/topic/Reuters+Group+plc" &gt;Reuters Health&lt;/a&gt;) - Boys who are short due to underlying health problems are more likely than their female counterparts to be treated with growth hormone -- but the gap is not explained by a bias in doctors' recommendations for treatment, a new study suggests.&amp;amp;lt;/p&amp;amp;gt;&amp;amp;lt;p&amp;amp;gt;Growth hormone therapy may be prescribed to children with short stature due to certain medical ...</summary><category term="Health Care Issues"></category><category term="Kidney Failure"></category><category term="Endocrinology"></category><category term="Kidney and Urologic Health"></category><category term="Medical Treatments and Procedures"></category><category term="Medical Drug Therapy"></category><category term="Reuters Group plc"></category><category term="Oceania"></category><category term="Ian Hughes"></category><category term="Hormone Therapies"></category><category term="Health Disparities"></category></entry><entry><title>Keryx, FDA agree on colon cancer drug study goals</title><link href="http://www.factsaboutheadaches.com/article/Keryx%2C%20FDA%20agree%20on%20colon%20cancer%20drug%20study%20goals" rel="alternate"></link><updated>2010-02-22T12:18:12Z</updated><author><name>AP News</name></author><id>tag:www.factsaboutheadaches.com,2010-02-22:/article/Keryx%2C%20FDA%20agree%20on%20colon%20cancer%20drug%20study%20goals</id><summary type="html">&amp;amp;lt;div id="subtitle"&amp;amp;gt;&lt;a title="Keryx Biopharmaceuticals Inc." href="/topic/Keryx+Biopharmaceuticals+Inc." &gt;Keryx Biopharma&lt;/a&gt;, FDA agree on design of late-stage trial for drug against colorectal cancer&amp;amp;lt;/div&amp;amp;gt;&amp;amp;lt;div&amp;amp;gt;&amp;amp;lt;p&amp;amp;gt;Keryx Biopharmaceuticals Inc. said Wednesday it reached an agreement with regulators on the design of a late-stage study of its cancer drug candidate perifosine.&amp;amp;lt;/p&amp;amp;gt;&amp;amp;lt;p&amp;amp;gt;The agreement makes it more likely...</summary><category term="Financial Markets"></category><category term="Stock Performance"></category><category term="Cancer"></category><category term="Clinical Trials"></category><category term="Medical Treatments and Procedures"></category><category term="Medical Drug Therapy"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="Aeterna Zentaris Inc."></category><category term="Xeloda"></category><category term="Keryx Biopharmaceuticals Inc."></category><category term="Chemotherapy"></category></entry><entry><title>Hormone drugs for prostate cancer may hurt heart</title><link href="http://www.factsaboutheadaches.com/article/Hormone%20drugs%20for%20prostate%20cancer%20may%20hurt%20heart" rel="alternate"></link><updated>2010-02-22T12:54:59Z</updated><author><name>Reuters US Online Report Health News</name></author><id>tag:www.factsaboutheadaches.com,2010-02-22:/article/Hormone%20drugs%20for%20prostate%20cancer%20may%20hurt%20heart</id><summary type="html">&amp;amp;lt;div&amp;amp;gt;&amp;amp;lt;p&amp;amp;gt;WASHINGTON (&lt;a title="Reuters Group plc" href="/topic/Reuters+Group+plc" &gt;Reuters&lt;/a&gt;) - Prostate cancer treatments that cut off the supply of male hormone raise cholesterol, worsen blood sugar and make men fatter and thus likely raise the risk of heart attack, too, doctors said on Monday.&amp;amp;lt;/p&amp;amp;gt;&amp;amp;lt;p&amp;amp;gt;An advisory published in the &lt;a title="American Heart Association" href="/topic/American+Heart+Association" &gt;American Heart Association&lt;/a&gt;...</summary><category term="Cancer"></category><category term="Prostate Cancer"></category><category term="Internal Medicine"></category><category term="Metabolic Disorders"></category><category term="Diabetes"></category><category term="Medical Treatments and Procedures"></category><category term="Medical Drug Therapy"></category><category term="Sexual and Reproductive Health"></category><category term="Men's Health"></category><category term="Reuters Group plc"></category><category term="Maggie Fox"></category><category term="American Society for Therapeutic Radiology and Oncology"></category><category term="Cardiovascular Medicine"></category><category term="Hormone Therapies"></category><category term="Glenn Levine"></category></entry><entry><title>Poniard Pharma skids on picoplatin study data</title><link href="http://www.factsaboutheadaches.com/article/Poniard%20Pharma%20skids%20on%20picoplatin%20study%20data" rel="alternate"></link><updated>2010-02-22T15:12:16Z</updated><author><name>AP News</name></author><id>tag:www.factsaboutheadaches.com,2010-02-22:/article/Poniard%20Pharma%20skids%20on%20picoplatin%20study%20data</id><summary type="html">&amp;amp;lt;div id="subtitle"&amp;amp;gt;&lt;a title="Poniard Pharmaceuticals Inc." href="/topic/Poniard+Pharmaceuticals+Inc." &gt;Poniard Pharma&lt;/a&gt; tumbles as data raises doubts on cancer drug's effectiveness, side effects&amp;amp;lt;/div&amp;amp;gt;&amp;amp;lt;div&amp;amp;gt;&amp;amp;lt;p&amp;amp;gt;Shares of Poniard Pharmaceuticals Inc. dropped Monday due to safety concerns about its experimental chemotherapy drug picoplatin.&amp;amp;lt;/p&amp;amp;gt;&amp;amp;lt;p&amp;amp;gt;On Sunday, Poniard reported results from a midstage clinical study tha...</summary><category term="Financial Markets"></category><category term="Stock Performance"></category><category term="Cancer"></category><category term="Medical Treatments and Procedures"></category><category term="Medical Drug Therapy"></category><category term="South San Francisco"></category><category term="Joel Sendek"></category><category term="Lazard Capital Markets LLC"></category><category term="Poniard Pharmaceuticals Inc."></category><category term="Blood Disorders"></category><category term="Chemotherapy"></category></entry><entry><title>Roche drug keeps patients cancer-free longer</title><link href="http://www.factsaboutheadaches.com/article/Roche%20drug%20keeps%20patients%20cancer-free%20longer" rel="alternate"></link><updated>2010-02-22T17:16:16Z</updated><author><name>Reuters US Online Report Health News</name></author><id>tag:www.factsaboutheadaches.com,2010-02-22:/article/Roche%20drug%20keeps%20patients%20cancer-free%20longer</id><summary type="html">&amp;amp;lt;div&amp;amp;gt;&amp;amp;lt;p&amp;amp;gt;ZURICH (&lt;a title="Reuters Group plc" href="/topic/Reuters+Group+plc" &gt;Reuters&lt;/a&gt;) - Roche's cancer drug &lt;a title="Xeloda" href="/topic/Xeloda" &gt;Xeloda&lt;/a&gt; enabled elderly patients being treated for colorectal cancer to live free of the disease for longer, the world's largest maker of cancer drugs said on Thursday.&amp;amp;lt;/p&amp;amp;gt;&amp;amp;lt;p&amp;amp;gt;A study showed that patients above the age of 65 or 70 years who took Xeloda, or capecitabine, with &lt;a title="Xel...</summary><category term="Cancer"></category><category term="Colorectal Cancer"></category><category term="Medical Treatments and Procedures"></category><category term="Medical Drug Therapy"></category><category term="Reuters Group plc"></category><category term="Xelox"></category><category term="Xeloda"></category><category term="Katie Reid"></category><category term="Chemotherapy"></category></entry><entry><title>A New Vaccine For Leukaemia</title><link href="http://www.factsaboutheadaches.com/article/A%20New%20Vaccine%20For%20Leukaemia" rel="alternate"></link><updated>2010-02-22T17:21:22Z</updated><author><name>isnare</name></author><id>tag:www.factsaboutheadaches.com,2010-02-22:/article/A%20New%20Vaccine%20For%20Leukaemia</id><summary type="html">&lt;p&gt;In a breakthrough find, British scientists have developed a treatment that can stop leukaemia. This can be done by vaccination in the stage right after a bone marrow transplant or chemotherapy. The drug can activate the immune system of the body against leukaemia. In fact, in the future it can be used to treat other forms of cancer.&amp;amp;lt;br&amp;amp;gt;&amp;amp;lt;br&amp;amp;gt;Leukaemia is cancer of the bone marrow and wide blood cells. Its treatment is usually done in two phases. The first phase is ch...</summary><category term="Cancer"></category><category term="Leukemia"></category><category term="Medical Treatments and Procedures"></category><category term="Medical Drug Therapy"></category><category term="Vaccines"></category><category term="Chemotherapy"></category></entry><entry><title>OSI reports 17 percent boost in Tarceva sales</title><link href="http://www.factsaboutheadaches.com/article/OSI%20reports%2017%20percent%20boost%20in%20Tarceva%20sales" rel="alternate"></link><updated>2010-02-22T21:35:47Z</updated><author><name>AP News</name></author><id>tag:www.factsaboutheadaches.com,2010-02-22:/article/OSI%20reports%2017%20percent%20boost%20in%20Tarceva%20sales</id><summary type="html">&amp;amp;lt;div id="subtitle"&amp;amp;gt;&lt;a title="OSI Pharmaceuticals Inc." href="/topic/OSI+Pharmaceuticals+Inc." &gt;OSI Pharmaceuticals&lt;/a&gt; says 4Q sales of cancer drug &lt;a title="Tarceva" href="/topic/Tarceva" &gt;Tarceva&lt;/a&gt; rise 17 percent in &lt;a title="United States" href="/topic/United+States" &gt;US&lt;/a&gt;, abroad&amp;amp;lt;/div&amp;amp;gt;&amp;amp;lt;div&amp;amp;gt;&amp;amp;lt;p&amp;amp;gt;OSI Pharmaceuticals Inc. said Tuesday sales of its cancer drug Tarceva jumped 17 percent in the U.S. and abroad during the fourth quarter.&amp;am...</summary><category term="Cancer"></category><category term="Lung Cancer"></category><category term="Medical Treatments and Procedures"></category><category term="Medical Drug Therapy"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="Thomson Reuters Corporation"></category><category term="OSI Pharmaceuticals Inc."></category><category term="Chemotherapy"></category></entry><entry><title>Medications Used in Joint Pain Relief</title><link href="http://www.factsaboutheadaches.com/article/Medications%20Used%20in%20Joint%20Pain%20Relief" rel="alternate"></link><updated>2010-02-23T13:48:04Z</updated><author><name>isnare</name></author><id>tag:www.factsaboutheadaches.com,2010-02-23:/article/Medications%20Used%20in%20Joint%20Pain%20Relief</id><summary type="html">&lt;p&gt;Joint pain is so excruciating that people who have experienced it even just once cringe at the thought of its recurrence. There are many ways to relieve joint pains. However, each joint pain relief is dependent on what causes the pain. Could it be brought about by arthritis, injury, or gout?&amp;amp;lt;br&amp;amp;gt;&amp;amp;lt;br&amp;amp;gt;Whichever the cause is, one of the most common treatments to joint pains is drug treatment. However, you must bear in mind that if you are experiencing joint pains due o...</summary><category term="Arthritis"></category><category term="Gout"></category><category term="Rheumatoid Arthritis"></category><category term="Autoimmune Disorders"></category><category term="Orthopedics"></category><category term="Medical Treatments and Procedures"></category><category term="Medical Drug Therapy"></category><category term="Pain Management"></category><category term="Clinical Immunology"></category></entry><entry><title>Diagnosis and Treatment of Epithelial Ovarian Cancer</title><link href="http://www.factsaboutheadaches.com/article/Diagnosis%20and%20Treatment%20of%20Epithelial%20Ovarian%20Cancer" rel="alternate"></link><updated>2010-02-23T15:30:23Z</updated><author><name>isnare</name></author><id>tag:www.factsaboutheadaches.com,2010-02-23:/article/Diagnosis%20and%20Treatment%20of%20Epithelial%20Ovarian%20Cancer</id><summary type="html">&lt;p&gt;Ovarian cancer represents about 25% of all female genital tract malignancies. However, there are more deaths from ovarian cancer each year in the &lt;a title="United States" href="/topic/United+States" &gt;United States&lt;/a&gt; than from endometrial cancer and cervical cancer combined.  The lifetime risk of developing spontaneous ovarian cancer is about 1.7%.  Epithelial ovarian cancer was expected cause 15,520 deaths in 2008.  Mean age at diagnosis is 60.  There has been a significant improvement in t...</summary><category term="Cancer"></category><category term="Colorectal Cancer"></category><category term="Ovarian Cancer"></category><category term="Health Care Issues"></category><category term="Genetic Testing"></category><category term="Medical Treatments and Procedures"></category><category term="Medical Drug Therapy"></category><category term="Women's Health"></category><category term="Chemotherapy"></category></entry><entry><title>FDA says OSI drug effective against lung cancer</title><link href="http://www.factsaboutheadaches.com/article/FDA%20says%20OSI%20drug%20effective%20against%20lung%20cancer" rel="alternate"></link><updated>2010-02-23T16:21:17Z</updated><author><name>AP News</name></author><id>tag:www.factsaboutheadaches.com,2010-02-23:/article/FDA%20says%20OSI%20drug%20effective%20against%20lung%20cancer</id><summary type="html">&amp;amp;lt;div id="subtitle"&amp;amp;gt;FDA says OSI's &lt;a title="Tarceva" href="/topic/Tarceva" &gt;Tarceva&lt;/a&gt; appears effective against lung cancer as chemotherapy follow-up&amp;amp;lt;/div&amp;amp;gt;&amp;amp;lt;div&amp;amp;gt;&amp;amp;lt;p&amp;amp;gt;Federal health regulators say OSI Pharmaceutical's Tarceva slows the progression of lung cancer and extends patients' lives when used as a follow-up to chemotherapy.&amp;amp;lt;/p&amp;amp;gt;&amp;amp;lt;p&amp;amp;gt;The &lt;a title="Food and Drug Administration" href="/topic/Food+and+Drug+Administ...</summary><category term="Cancer"></category><category term="Lung Cancer"></category><category term="Prostate Cancer"></category><category term="Medical Treatments and Procedures"></category><category term="Medical Drug Therapy"></category><category term="Men's Health"></category><category term="Melville"></category><category term="South San Francisco"></category><category term="OSI Pharmaceuticals Inc."></category><category term="Taxotere"></category><category term="Chemotherapy"></category></entry></feed>